Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-043381
Filing Date
2021-02-16
Accepted
2021-02-16 07:32:28
Documents
1
Group Members
VERSANT AFFILIATES FUND V, L.P.VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.VERSANT VANTAGE I GP, L.P.VERSANT VANTAGE I GP-GP, LLCVERSANT VANTAGE I, L.P.VERSANT VENTURE CAPITAL V (CANADA) LPVERSANT VENTURE CAPITAL V, L.P.VERSANT VENTURES V (CANADA), L.P.VERS

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d121610dsc13ga.htm SC 13G/A 172212
  Complete submission text file 0001193125-21-043381.txt   174132
Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-2215
Versant Ventures V, LLC (Filed by) CIK: 0001619298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Subject) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91159 | Film No.: 21632467
SIC: 2834 Pharmaceutical Preparations